サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1540966

動物用ワクチン市場レポート：ワクチンタイプ、技術、投与経路、流通チャネル、地域別、2024年～2032年

Veterinary Vaccines Market Report by Vaccine Type, Technology, Route of Administration, Distribution Channel, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.35円
動物用ワクチン市場レポート：ワクチンタイプ、技術、投与経路、流通チャネル、地域別、2024年～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の動物用ワクチン市場規模は2023年に136億米ドルに達しました。今後、IMARC Groupは、2024年から2032年の間に8.12%の成長率（CAGR）を示し、2032年までに市場は280億米ドルに達すると予測しています。

動物用ワクチンは生物学的に調製された予防接種であり、家畜や野生動物に非経口および経口投与され、病気そのものを引き起こすことなく防御免疫反応を刺激します。動物用ワクチンには、不活化ワクチン、弱毒生ワクチン、組み換えワクチンなどがあり、一般的な薬剤として使用されています。これらの接種は、動物の苦痛を軽減し、免疫効率を高め、様々な伝染性人獣共通感染症の発症や伝播のリスクを予防するのに役立ちます。これとは別に、動物用ワクチンは費用対効果が高く、信頼性が高く、長期的な予防が可能であるため、世界中の家畜の増産にも使用されています。

動物用ワクチン市場の動向：

世界の動物用ワクチン市場の主な原動力は、効果的な予防接種製品に対する需要の高まりと、様々な感染性伝染病の有病率の上昇です。この背景には、世界中でコンパニオンアニマルや家畜動物が飼われるようになり、ペットの健康への関心が高まっていることがあります。これに伴い、新規の動物用ワクチン製造手順を改善するための製薬セクターにおける政府による大規模な投資が、もう一つの成長促進要因として作用しています。さらに、製品の安定性、有効性、投与経路を改善したデオキシリボ核酸（DNA）ワクチンやリボ核酸（RNA）ワクチンのイントロダクションが市場成長に寄与しています。このほか、注射針を使用しない筋肉内ワクチン注射の技術革新や、安全性の向上や痛みの軽減といった有益な特性に関する消費者の意識の高まりが、市場成長を後押ししています。さらに、牛乳、食肉、皮革、卵、羊毛などの家畜由来製品から病気を媒介する微生物の感染を防ぐための動物用ワクチンのニーズが高まっていることも、市場成長を積極的に刺激しています。ヘルスケアインフラの大幅な発展、進行中の研究開発（R&D）活動、動物用ワクチンの効率性を高めるための主要企業間の戦略的提携といったその他の要因も、市場に明るい展望をもたらしています。

本レポートで扱う主な質問

  • 世界の動物用ワクチン市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が世界の動物用ワクチン市場に与えた影響は？
  • 主要地域市場とは？
  • ワクチンの種類に基づく市場内訳は？
  • 技術別の市場内訳は？
  • 投与経路に基づく市場内訳は？
  • 流通チャネル別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界の動物用ワクチン市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の動物用ワクチン市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：ワクチンタイプ別

  • 家畜ワクチン
    • 市場動向
    • 主要セグメント
      • 牛ワクチン
      • 家禽ワクチン
      • 豚ワクチン
      • その他
    • 市場予測
  • ペット用ワクチン
    • 市場動向
    • 主要セグメント
      • 犬のワクチン
      • 猫のワクチン
      • 馬用ワクチン
    • 市場予測

第7章 市場内訳：技術別

  • 弱毒生ワクチン
    • 市場動向
    • 市場予測
  • 不活化ワクチン
    • 市場動向
    • 市場予測
  • トキソイドワクチン
    • 市場動向
    • 市場予測
  • 組み換えワクチン
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：投与経路別

  • 皮下
    • 市場動向
    • 市場予測
  • 筋肉
    • 市場動向
    • 市場予測
  • 鼻腔
    • 市場動向
    • 市場予測

第9章 市場内訳：流通チャネル別

  • 動物病院
    • 市場動向
    • 市場予測
  • 獣医クリニック
    • 市場動向
    • 市場予測
  • 薬局とドラッグストア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Elanco Animal Health Incorporated
    • Hester Biosciences Limited
    • HIPRA
    • Indian Immunologicals Limited
    • Merck & Co. Inc.
    • Neogen Corporation
    • Phibro Animal Health Corporation
    • Virbac SA
    • Zoetis Inc.
図表

List of Figures

  • Figure 1: Global: Veterinary Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Veterinary Vaccines Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Veterinary Vaccines Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Veterinary Vaccines Market: Breakup by Vaccine Type (in %), 2023
  • Figure 5: Global: Veterinary Vaccines Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Veterinary Vaccines Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Veterinary Vaccines Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Veterinary Vaccines Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Veterinary Vaccines (Livestock Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Veterinary Vaccines (Livestock Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Veterinary Vaccines (Companion Animal Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Veterinary Vaccines (Companion Animal Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Veterinary Vaccines (Inactivated Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Veterinary Vaccines (Inactivated Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Veterinary Vaccines (Toxoid Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Veterinary Vaccines (Toxoid Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Veterinary Vaccines (Recombinant Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Veterinary Vaccines (Recombinant Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Veterinary Vaccines (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Veterinary Vaccines (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Veterinary Vaccines (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Veterinary Vaccines (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Veterinary Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Veterinary Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Veterinary Vaccines (Intranasal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Veterinary Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Veterinary Vaccines (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Veterinary Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Veterinary Vaccines (Veterinary Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Veterinary Vaccines (Veterinary Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Veterinary Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Veterinary Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Veterinary Vaccines Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Veterinary Vaccines Industry: SWOT Analysis
  • Figure 87: Global: Veterinary Vaccines Industry: Value Chain Analysis
  • Figure 88: Global: Veterinary Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Veterinary Vaccines Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Veterinary Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2024-2032
  • Table 3: Global: Veterinary Vaccines Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Veterinary Vaccines Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Veterinary Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Veterinary Vaccines Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Veterinary Vaccines Market: Competitive Structure
  • Table 8: Global: Veterinary Vaccines Market: Key Players
目次
Product Code: SR112024A6493

The global veterinary vaccines market size reached US$ 13.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.0 Billion by 2032, exhibiting a growth rate (CAGR) of 8.12% during 2024-2032.

Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases. Apart from this, veterinary vaccines are cost-effective, reliable, and offer long-term prevention, due to which they are also used to increase the production of livestock across the globe.

Veterinary Vaccines Market Trends:

The global veterinary vaccines market is majorly driven by the increasing demand for effective immunization products and the rising prevalence of various infectious epizootic disorders. This can be further attributed to the domestication of both companion and livestock animals across the globe and the enhanced focus on pet health. In line with this, extensive investments by governments in the pharmaceutical sector to improve novel veterinary vaccine manufacturing procedures are acting as another growth-inducing factor. Additionally, the introduction of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) vaccines with improved product stability, efficacy, and route administration approach is contributing to the market growth. Besides this, the innovation of intramuscular needle-free vaccine injections and growing awareness amongst consumers regarding their beneficial properties, such as enhanced safety and less pain, is propelling the market growth. Moreover, the fueling need for veterinary vaccines to prevent the transmission of disease-carrying microbes from livestock-based products, including milk, meat, leather, eggs, and wool, is positively stimulating the market growth. Other factors, such as significant improvements in the healthcare infrastructure, ongoing research and development (R&D) activities, and strategic collaborations amongst key players to enhance the efficiency of veterinary vaccines, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary vaccines market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on vaccine type, technology, route of administration and distribution channel.

Breakup by Vaccine Type:

Livestock Vaccines

Bovine Vaccines

Poultry Vaccines

Porcine Vaccines

Others

Companion Animal Vaccines

Canine Vaccines

Feline Vaccines

Equine Vaccines

Breakup by Technology:

Attenuated Live Vaccines

Inactivated Vaccines

Toxoid Vaccines

Recombinant Vaccines

Others

Breakup by Route of Administration:

Subcutaneous

Intramuscular

Intranasal

Breakup by Distribution Channel:

Veterinary Hospitals

Veterinary Clinics

Pharmacies and Drug Stores

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Incorporated, Hester Biosciences Limited, HIPRA, Indian Immunologicals Limited, Merck & Co. Inc., Neogen Corporation, Phibro Animal Health Corporation, Virbac SA and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global veterinary vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global veterinary vaccines market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Livestock Vaccines
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Bovine Vaccines
      • 6.1.2.2 Poultry Vaccines
      • 6.1.2.3 Porcine Vaccines
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Companion Animal Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Canine Vaccines
      • 6.2.2.2 Feline Vaccines
      • 6.2.2.3 Equine Vaccines
    • 6.2.3 Market Forecast

7 Market Breakup by Technology

  • 7.1 Attenuated Live Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Inactivated Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Toxoid Vaccines
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Recombinant Vaccines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Subcutaneous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Intranasal
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Veterinary Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmacies and Drug Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Boehringer Ingelheim International GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Ceva Sante Animale
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Elanco Animal Health Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Hester Biosciences Limited
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 HIPRA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Indian Immunologicals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Neogen Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Phibro Animal Health Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Virbac SA
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Zoetis Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials